mitomycin has been researched along with Endophthalmitis in 31 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0." | 8.31 | Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023) |
"Two patients developed bleb-related ocular infection attributable to Gemella haemolysans and Gemella morbillorum after trabeculectomy with adjunctive mitomycin C." | 7.75 | Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C. ( Katada, T; Kawakami, H; Mikamo, H; Mochizuki, K; Sawada, A; Watanabe, K; Yamamoto, T, 2009) |
"To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 7.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
"To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 7.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
"To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty." | 7.70 | Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999) |
"To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis." | 7.69 | Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996) |
"To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 7.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
"With the increased use of intraoperative antifibrotic (eg, mitomycin and fluorouracil) as an adjunct to standard trabeculectomy, an increased incidence is seen of late-onset filtering bleb-related infections." | 4.82 | Glaucoma-filtering bleb infections. ( Mac, I; Soltau, JB, 2003) |
"The purpose of the study was to investigate the incidence for endophthalmitis and blebitis after deep sclerectomy (DS) and trabeculectomy with routine use of Mitomycin C (MMC) 0." | 4.31 | Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C. ( Harju, M; Kankainen, T, 2023) |
"Rabbit model studies suggested better morphology blebs with equal intraocular pressure (IOP) efficacy as a standard mitomycin C (MMC) trabeculectomy using a novel slow-release drug delivery antifibrotic system delivering small quantities of MMC and 5-fluorouracil (5-FU)." | 3.91 | Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model. ( Ayyala, RS; Blake, D; Fullerton, M; Greenberg, E; John, V; Le, C; Mancera, N; Margo, C; Muddasani, N; Satija, C; Singh, S; Swann, FB; Wall, J; Zhang, Z; Zurakowski, D, 2019) |
"Two patients developed bleb-related ocular infection attributable to Gemella haemolysans and Gemella morbillorum after trabeculectomy with adjunctive mitomycin C." | 3.75 | Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C. ( Katada, T; Kawakami, H; Mikamo, H; Mochizuki, K; Sawada, A; Watanabe, K; Yamamoto, T, 2009) |
"To evaluate the safety and effectiveness of trabeculectomy with mitomycin C in the management of childhood glaucoma." | 3.74 | Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. ( Borges-Giampani, AS; Carani, JC; Giampani, J; Oltrogge, EW; Susanna, R, 2008) |
"To assess the outcomes of patients who had late infections after undergoing filtering surgery with mitomycin C with respect to treatment, resultant vision, and maintenance of intraocular pressure." | 3.72 | Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. ( Lehrer, RA; Muckley, ED, 2004) |
"To present two cases of delayed-onset postoperative endophthalmitis following trabeculectomy combined with mitomycin C for secondary glaucoma after penetrating keratoplasty." | 3.70 | Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Akova, YA; Bulut, S; Dabil, H; Duman, S, 1999) |
"The use of adjunctive antimetabolites such as 5-fluorouracil (5-FU) and mitomycin C (MMC) in trabeculectomy has caused an increased concern as to the risk of bleb-associated endophthalmitis." | 3.70 | Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. ( Frucht-Pery, J; Solomon, A; Ticho, U, 1999) |
"To determine whether filtering blebs resulting from adjunctive use of mitomycin C (MMC) leads to an increased risk of endophthalmitis." | 3.69 | Bleb-related endophthalmitis after trabeculectomy with mitomycin C. ( Bergstrom, TJ; Higginbotham, EJ; Karp, KO; Lichter, PR; Musch, DC; Skuta, GL; Stevens, RK, 1996) |
"To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin." | 3.69 | Endophthalmitis after filtering surgery with mitomycin. ( Flynn, HW; Greenfield, DS; Kangas, TA; Miller, MP; Palmberg, PF; Suñer, IJ, 1996) |
"The mean follow-up time after treatment for endophthalmitis was 6." | 2.41 | Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. ( Budenz, DL; Flynn, HW; Scott, IU; Song, A, 2002) |
"Postoperative endophthalmitis is a devastating complication after trabeculectomy." | 1.40 | Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. ( Al-ahramy, AM; Lundström, M; Montan, P; Wallin, Ö, 2014) |
"Postoperative complications were: ocular hypotony (1 case), bleb fibrosis (2 cases), bleb-related endophthalmitis (1 case)." | 1.36 | [Non-pentrating deep sclerectomy--between safety and efficacy]. ( Cantemir, A; Chiseliţă, D; Ilieş, I, 2010) |
"To report delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis." | 1.32 | Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. ( Cruz-Villegas, V; Flynn, HW; Miller, D; Scott, IU, 2004) |
"In the study 6 patients with cystic blebs after trabeculectomy with mitomycin C was presented." | 1.32 | [Surgical management of pathologic filtering blebs in pediatric glaucoma]. ( Chipczyńska, B; Grałek, M; Kanigowska, K; Klimczak-Slaczka, D, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (22.58) | 18.2507 |
2000's | 12 (38.71) | 29.6817 |
2010's | 10 (32.26) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
Authors | Studies |
---|---|
Kankainen, T | 1 |
Harju, M | 1 |
Khamar, M | 1 |
Bhojwani, D | 1 |
Patel, P | 1 |
Vasavada, A | 1 |
Seth, PK | 1 |
Sharma, S | 2 |
Senthil, S | 1 |
Kerr, NM | 1 |
Wang, J | 1 |
Sandhu, A | 1 |
Harasymowycz, PJ | 1 |
Barton, K | 3 |
Swann, FB | 1 |
Singh, S | 1 |
Blake, D | 1 |
John, V | 1 |
Le, C | 1 |
Fullerton, M | 1 |
Margo, C | 1 |
Zhang, Z | 1 |
Muddasani, N | 1 |
Wall, J | 1 |
Satija, C | 1 |
Greenberg, E | 1 |
Mancera, N | 1 |
Zurakowski, D | 1 |
Ayyala, RS | 1 |
Wallin, Ö | 1 |
Al-ahramy, AM | 1 |
Lundström, M | 1 |
Montan, P | 1 |
Gupta, S | 1 |
Wadhwani, M | 1 |
Sehgal, V | 1 |
Dada, T | 1 |
Cherof, AM | 1 |
SooHoo, JR | 1 |
Kahook, MY | 1 |
Seibold, LK | 1 |
Giampani, J | 1 |
Borges-Giampani, AS | 1 |
Carani, JC | 1 |
Oltrogge, EW | 1 |
Susanna, R | 1 |
Mochizuki, K | 2 |
Kumada, M | 1 |
Suemori, S | 1 |
Kawakami, H | 2 |
Sawada, A | 2 |
Yamamoto, T | 2 |
Mikamo, H | 2 |
Katada, T | 1 |
Watanabe, K | 1 |
Carpineto, P | 1 |
Agnifili, L | 1 |
Nubile, M | 1 |
Fasanella, V | 1 |
Doronzo, E | 1 |
Mastropasqua, A | 1 |
Ciancaglini, M | 1 |
Chiseliţă, D | 1 |
Cantemir, A | 1 |
Ilieş, I | 1 |
Rai, P | 1 |
Kotecha, A | 1 |
Kaltsos, K | 1 |
Ruddle, JB | 1 |
Murdoch, IE | 1 |
Bunce, C | 2 |
Zahid, S | 1 |
Musch, DC | 2 |
Niziol, LM | 1 |
Lichter, PR | 2 |
Mac, I | 1 |
Soltau, JB | 1 |
Scott, IU | 2 |
Cruz-Villegas, V | 1 |
Flynn, HW | 3 |
Miller, D | 1 |
Muckley, ED | 1 |
Lehrer, RA | 1 |
Klimczak-Slaczka, D | 1 |
Grałek, M | 1 |
Chipczyńska, B | 1 |
Kanigowska, K | 1 |
Higginbotham, EJ | 1 |
Stevens, RK | 1 |
Karp, KO | 1 |
Bergstrom, TJ | 1 |
Skuta, GL | 1 |
Greenfield, DS | 3 |
Suñer, IJ | 1 |
Miller, MP | 1 |
Kangas, TA | 1 |
Palmberg, PF | 1 |
Gupta, N | 1 |
Weinreb, RN | 1 |
Waheed, S | 1 |
Ritterband, DC | 1 |
Liebmann, JM | 1 |
Sidoti, PA | 1 |
Ritch, R | 1 |
Akova, YA | 1 |
Bulut, S | 1 |
Dabil, H | 1 |
Duman, S | 1 |
Solomon, A | 1 |
Ticho, U | 1 |
Frucht-Pery, J | 1 |
Lehmann, OJ | 1 |
Matheson, MM | 1 |
Maurino, V | 1 |
Khaw, PT | 1 |
Wormald, R | 1 |
Paciuc, M | 1 |
Velasco, CF | 1 |
Beck, AD | 1 |
Freedman, SF | 1 |
DeBry, PW | 1 |
Perkins, TW | 1 |
Heatley, G | 1 |
Kaufman, P | 1 |
Brumback, LC | 1 |
Song, A | 1 |
Budenz, DL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma[NCT02964676] | 246 participants (Anticipated) | Interventional | 2017-01-31 | Not yet recruiting | |||
[NCT02665884] | 40 participants (Anticipated) | Observational | 2016-02-29 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for mitomycin and Endophthalmitis
Article | Year |
---|---|
Glaucoma-filtering bleb infections.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Endophthalmitis; Fibrosis; Filtering Surgery; F | 2003 |
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Bacteria; Endophthalmitis; Eye Infections, Bacteri | 2002 |
1 trial available for mitomycin and Endophthalmitis
Article | Year |
---|---|
Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS).
Topics: Antimetabolites; Cataract Extraction; Endophthalmitis; Fluorouracil; Follow-Up Studies; Glaucoma, Op | 2013 |
28 other studies available for mitomycin and Endophthalmitis
Article | Year |
---|---|
Endophthalmitis and blebitis following deep sclerectomy and trabeculectomy with routine use of mitomycin C.
Topics: Cohort Studies; Endophthalmitis; Glaucoma; Humans; Mitomycin; Retrospective Studies; Trabeculectomy | 2023 |
Leftover mitomycin-c sponge causing blebitis.
Topics: Endophthalmitis; Humans; Male; Mitomycin; Nucleic Acid Synthesis Inhibitors; Postoperative Complicat | 2019 |
Bleb-related tuberculous endophthalmitis following combined phacoemulsification and trabeculectomy with mitomycin C.
Topics: Aged; Antitubercular Agents; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Mycobacterium tuber | 2020 |
Ab Interno Gel Implant-associated Bleb-related Infection.
Topics: Aged; Alkylating Agents; Anti-Bacterial Agents; Endophthalmitis; Female; Follow-Up Studies; Gelatin; | 2018 |
Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model.
Topics: Absorbable Implants; Animals; Drug Delivery Systems; Drug Implants; Drug Liberation; Endophthalmitis | 2019 |
Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract Extraction; Conjunctiva; | 2014 |
Blebitis with scleral abscess in a case of operated trabeculectomy with mitomycin C and a subcunjunctival ologen implant.
Topics: Abscess; Alkylating Agents; Anti-Bacterial Agents; Ceftriaxone; Collagen; Drug Therapy, Combination; | 2014 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endop | 2016 |
Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.
Topics: Adolescent; Age Distribution; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modalit | 2008 |
Streptococcus intermedius-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C.
Topics: Adult; Alkylating Agents; Anti-Bacterial Agents; Combined Modality Therapy; DNA, Bacterial; Drug The | 2009 |
Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C.
Topics: Adult; Anti-Bacterial Agents; Blister; Conjunctiva; Drug Therapy, Combination; Endophthalmitis; Eye | 2009 |
Conjunctival and corneal findings in bleb-associated endophthalmitis: an in vivo confocal microscopy study.
Topics: Aged; Aged, 80 and over; Blister; Case-Control Studies; Conjunctivitis; Endophthalmitis; Female; Gla | 2011 |
[Non-pentrating deep sclerectomy--between safety and efficacy].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Blister; Drug Therapy, Comb | 2010 |
Changing trends in the incidence of bleb-related infection in trabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Endophthalmitis; Eye Infecti | 2012 |
Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis.
Topics: Antifungal Agents; Blister; Combined Modality Therapy; Cryotherapy; Endophthalmitis; Eye Infections, | 2004 |
Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cataract Extraction | 2004 |
[Surgical management of pathologic filtering blebs in pediatric glaucoma].
Topics: Adolescent; Anti-Bacterial Agents; Blister; Child; Endophthalmitis; Female; Glaucoma; Humans; Male; | 2004 |
Bleb-related endophthalmitis after trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Aqueous Humor; Bacteria | 1996 |
Endophthalmitis after filtering surgery with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bact | 1996 |
Filtering bleb infection as a complication of orthokeratology.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Contact Lenses; Drug Therapy, Combination | 1997 |
Bleb-related ocular infection in children after trabeculectomy with mitomycin C.
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Child; Child, Preschool; | 1997 |
Bleb-related ocular infection.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Drug Therapy, Combination; Endophthalmitis; Exfoliation | 1998 |
Late bleb-related endophthalmitis after trabeculectomy with mitomycin C.
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; | 1999 |
Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Endophthalmitis; Female; Filtration; Fluoro | 1999 |
Risk factors for development of post-trabeculectomy endophthalmitis.
Topics: Aged; Antimetabolites; Case-Control Studies; Diabetes Complications; Endophthalmitis; Female; Fluoro | 2000 |
Trabeculectomy with mitomycin-C in pediatric glaucomas.
Topics: Child; Endophthalmitis; Glaucoma; Humans; Male; Mitomycin; Patient Education as Topic; Surgical Woun | 2001 |
Trabeculectomy with mitomycin-C in pediatric glaucomas.
Topics: Endophthalmitis; Glaucoma; Humans; Incidence; Infant; Mitomycin; Risk Factors; Surgical Wound Infect | 2001 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |